Clinical Trials Browser

Phase 3 × Completed × Metastatic Castration-resistant Prostate Cancer × Clear all

NCT02044354 2026-04-01

CABA-DOC

Phase 3 Completed

Metastatic Castration-resistant Prostate Cancer

NCT02987543 2023-10-06

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

Phase 3 Completed

387 enrolled 16 charts 3 FDA

Metastatic Castration-resistant Prostate Cancer